CATX - Perspective Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.33
DETAILS
HIGH:
$16.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$13.33
UPSIDE:
234.92%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.17 |
| Quick Ratio | 5.17 |
| Solvency Ratio | -1.666 |
| Cash Ratio | 1.07 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.97
Peers avg: 30.0
|
| PEG Ratio | -0.14 |
| Forward PEG | -0.14 |
| Price/Book | 0.98 |
| Price/Sales | 0.00 |
| Price/FCF | -2.13 |
| Price/Op Cash Flow | -2.46 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0061 |
| Debt/Equity | 0.0079 |
| Debt/Capital | 0.0078 |
| Long-Term Debt/Capital | 0.0048 |
| Financial Leverage | 1.29 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -2.876 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 115.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -100.11 |
| Interest Coverage | -302.0319 |
| Short-Term Operating Cash Flow Coverage | -132.40 |
| Operating Cash Flow Coverage | -50.67 |
| Capital Expenditure Coverage | -6.47 |
| Dividend + Capital Expenditure Coverage | -6.47 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -1.397 |
| Debt/Share | 0.0271 |
| Cash/Share | 1.96 |
| Book Value/Share | 2.80 |
| Tangible BV/Share | 2.26 |
| Equity/Share | 2.80 |
| Operating Cash Flow/Share | -1.117 |
| Capital Expenditure/Share | 0.173 |
| FCF/Share | -1.290 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.987 |
| Earnings Before Tax/EBIT | 0.920 |
| Price/Fair Value | 0.98 |
| Debt/Market Cap | 0.0080 |
| Effective Tax Rate | 0.8% |
| Enterprise Value Multiple | -1.73 |